Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma

This publication has 20 references indexed in Scilit:

• RAF/RAS oncogenes and mismatch-repair status
  Nature, 2002
• Mutations of the BRAF gene in human cancer
  Nature, 2002
• Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma
  The American Journal of Pathology, 2002
• The Hallmarks of Cancer
  Cell, 2000
• Detection and Clinical Correlations of ras Gene Mutations in Human Ovarian Tumors
  Oncology, 1999
• Expression of the Farnesyltransferase β-Subunit Gene in Human Ovarian Carcinoma: Correlation to K-rasMutation
  Gynecologic Oncology, 1997
• Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlations
  Genes, Chromosomes and Cancer, 1997
• Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero
  Cancer, 1996
• Alteration of the p53 Tumor Suppressor Gene Occurs Independently of K‐ras Activation and More Frequently in Serous Adenocarcinomas than in Other Common Epithelial Tumors of the Human Ovary
  Japanese Journal of Cancer Research, 1994
• Point Mutation of the ras Oncogene in Human Ovarian Cancer
  DNA and Cell Biology, 1993